Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 21
Filtrar
1.
BMC Microbiol ; 22(1): 8, 2022 01 04.
Artigo em Inglês | MEDLINE | ID: mdl-34983374

RESUMO

BACKGROUND: Type 1 diabetes (T1D) is an autoimmune disease that is increasing in prevalence worldwide. One of the contributing factors to the pathogenesis of T1D is the composition of the intestinal microbiota, as has been demonstrated. in T1D patients, with some studies demonstrating a deficiency in their levels of Prevotella. We have isolated a strain of Prevotella histicola from a duodenal biopsy that has anti-inflammatory properties, and in addition, alters the development of autoimmune diseases in mouse models. Therefore, our hypothesis is that the oral administration of P. histicola might delay the development of T1D in the non-obese diabetic (NOD) mice. To assess this, we used the following materials and methods. Female NOD mice (ages 5-8 weeks) were administered every other day P. histicola that was cultured in-house. Blood glucose levels were measured every other week. Mice were sacrificed at various time points for histopathological analysis of the pancreas. Modulation of immune response by the commensal was tested by analyzing regulatory T-cells and NKp46+ cells using flow cytometry and intestinal cytokine mRNA transcript levels using quantitative RT-PCR. For microbial composition, 16 s rRNA gene analysis was conducted on stool samples collected at various time points. RESULTS: Administration of P. histicola in NOD mice delayed the onset of T1D. Beta diversity in the fecal microbiomes demonstrated that the microbial composition of the mice administered P. histicola was different from those that were not treated. Treatment with P. histicola led to a significant increase in regulatory T cells with a concomitant decrease in NKp46+ cells in the pancreatic lymph nodes as compared to the untreated group after 5 weeks of treatment. CONCLUSIONS: These observations suggest that P. histicola treatment delayed onset of diabetes by increasing the levels of regulatory T cells in the pancreatic lymph nodes. This preliminary work supports the rationale that enteral exposure to a non pathogenic commensal P. histicola be tested as a future therapy for T1D.


Assuntos
Diabetes Mellitus Tipo 1/dietoterapia , Microbioma Gastrointestinal/fisiologia , Prevotella/fisiologia , Probióticos/administração & dosagem , Animais , Bactérias/classificação , Bactérias/genética , Bactérias/isolamento & purificação , Citocinas/genética , Diabetes Mellitus Tipo 1/imunologia , Diabetes Mellitus Tipo 1/microbiologia , Duodeno/imunologia , Duodeno/microbiologia , Fezes/microbiologia , Feminino , Humanos , Camundongos , Camundongos Endogâmicos NOD , Pâncreas/imunologia , Pâncreas/patologia
2.
Clin Immunol ; 230: 108813, 2021 09.
Artigo em Inglês | MEDLINE | ID: mdl-34333094

RESUMO

Cigarette smoking has been implicated in the pathogenesis of seropositive rheumatoid arthritis (RA), as well as RA-associated lung disease. Fibrotic interstitial lung disease as well as emphysema occur in RA and cause substantial morbidity. We used arthritis-susceptible HLA-DQ8 transgenic mice to generate RA-associated lung disease. Mice were exposed to cigarette smoke (CS) prior to induction of arthritis, and subsequently injected with a low dose of bleomycin intra-tracheally to induce lung injury. Exposure of arthritic mice to both CS and bleomycin led to a significant reduction in lung compliance consistent with development of diffuse lung disease. Morphologic evaluation of the lung demonstrated areas of emphysematous change and co-existent fibrosis, consistent with a combined pattern of fibrosis and emphysema. These changes were accompanied by inflammatory cell infiltration and upregulation of fibrosis-associated genes. This humanized mouse model can serve as a valuable research tool to understand the pathogenesis of RA associated lung disease.


Assuntos
Artrite Reumatoide/complicações , Doenças Pulmonares Intersticiais/etiologia , Animais , Artrite Reumatoide/etiologia , Bleomicina/toxicidade , Fumar Cigarros/efeitos adversos , Colágeno/metabolismo , Modelos Animais de Doenças , Feminino , Expressão Gênica , Humanos , Pulmão/metabolismo , Pulmão/patologia , Complacência Pulmonar/efeitos dos fármacos , Doenças Pulmonares Intersticiais/patologia , Masculino , Camundongos , Camundongos Transgênicos , Enfisema Pulmonar/etiologia , Fibrose Pulmonar/etiologia
3.
Front Immunol ; 12: 609644, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34017324

RESUMO

Bacterial therapeutics are the emergent alternatives in treating autoimmune diseases such as Rheumatoid Arthritis [RA]. P. histicola MCI 001 is one such therapeutic bacterium that has been proven to treat autoimmune diseases such as RA and multiple sclerosis [MS] in animal models. The present study characterized P. histicola MCI 001 isolated from a human duodenal biopsy, and evaluated its impact on the gut microbial and metabolic profile in a longitudinal study using the collagen-induced arthritis model in HLA-DQ8.AEo transgenic mice. P. histicola MCI 001 though closely related to the type strain of P. histicola, DSM 19854, differed in utilizing glycerol. In culture, P. histicola MCI 001 produced vitamins such as biotin and folate, and was involved in digesting complex carbohydrates and production of acetate. Colonization study showed that duodenum was the predominant niche for the gavaged MCI 001. A longitudinal follow-up of gut microbial profile in arthritic mice treated with MCI 001 suggested that dysbiosis caused due to arthritis was partially restored to the profile of naïve mice after treatment. A taxon-level analysis suggested an expansion of intestinal genus Allobaculum in MCI001 treated arthritic mice. Eubiosis achieved post treatment with P. histicola MCI 001 was also reflected in the increased production of short-chain fatty acids [SCFAs]. Present study suggests that the treatment with P. histicola MCI 001 leads to an expansion of Allobaculum by increasing the availability of simple carbohydrates and acetate. Restoration of microbial profile and metabolites like butyrate induce immune and gut homeostasis.


Assuntos
Terapia Biológica/métodos , Butiratos/metabolismo , Prevotella/fisiologia , Simbiose , Adaptação Fisiológica , Animais , Artrite Reumatoide/diagnóstico , Artrite Reumatoide/etiologia , Artrite Reumatoide/metabolismo , Artrite Reumatoide/terapia , Ácidos e Sais Biliares/farmacologia , Modelos Animais de Doenças , Ácidos Graxos Voláteis/metabolismo , Suco Gástrico , Microbioma Gastrointestinal , Humanos , Concentração de Íons de Hidrogênio , Camundongos , Camundongos Transgênicos , Prevotella/classificação , Prevotella/efeitos dos fármacos , Prevotella/genética
4.
Vitam Horm ; 115: 367-399, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33706954

RESUMO

Health and lifespan disparities between sexes are dependent on the immune responses. Men and women have different life styles which determine the environment, nutritional requirements and their interactions with the sex hormones. Sexual dimorphism in innate and adaptive immunity determines responses to infections and other environmental factors regulating health and diseases. Sex hormones regulate immune responses through the expression of receptors which differ for female and male hormones. Estrogen receptors are expressed in brain, lymphoid tissue cells and many immune cells while androgen receptors are limited in expression. Genetic, epigenetic factors and X chromosome linked immune function genes are important in enhanced adaptive immunity in females, leading to production of higher levels of antibodies compared to males. Different nutritional requirements and hormonal control of the mucosal microbiome and its function regulate mucosal immunity. Hormonal changes during various aspects of life and during aging control immune senescence. Evolutionarily, females have an advantage during young age when they are protected from infections by heightened immune reactivity though during aging that can lead to pathologies. Considering the sexual dimorphism in immunity, guidelines need to be established for sex-based treatments for optimal response.


Assuntos
Hormônios Esteroides Gonadais , Caracteres Sexuais , Animais , Feminino , Hormônios Esteroides Gonadais/metabolismo , Hormônios , Masculino
5.
Nat Rev Rheumatol ; 15(10): 581-596, 2019 10.
Artigo em Inglês | MEDLINE | ID: mdl-31455869

RESUMO

Rheumatoid arthritis (RA) is a chronic autoimmune disorder that causes joint inflammation and damage. Extra-articular manifestations occur in many patients and can include lung involvement in the form of airway or parenchymal inflammation and fibrosis. Although the pathophysiology of articular RA has been extensively investigated, the mechanisms causing airway and parenchymal lung disease are not well defined. Infections, cigarette-smoking, mucosal dysbiosis, host genetics and premature senescence are all potentially important contributors to the development of lung disease in patients with RA. RA-associated lung disease (which can predate the onset of articular disease by many years) probably originates from chronic airway and alveolar epithelial injury that occurs in an individual with a genetic background that permits the development of autoimmunity, leading to chronic inflammation and subsequent airway and lung parenchymal remodelling and fibrosis. Further investigations into the specific mechanisms by which lung disease develops in RA will be crucial for the development of effective therapies. Identifying mechanisms by which environmental and host factors cooperate in the induction of autoimmunity in the lung might also help to establish the order of early events in RA.


Assuntos
Artrite Reumatoide/complicações , Autoanticorpos/imunologia , Autoimunidade , Inflamação/imunologia , Pneumopatias/etiologia , Artrite Reumatoide/imunologia , Humanos , Pneumopatias/imunologia , Fatores de Risco
6.
Clin Gastroenterol Hepatol ; 17(10): 1954-1968.e13, 2019 09.
Artigo em Inglês | MEDLINE | ID: mdl-30448593

RESUMO

BACKGROUND & AIMS: A higher proportion of female vs male patients receive a diagnosis of celiac disease. Little is known about sex-based differences in the prevalence of celiac disease in undiagnosed populations. We aimed to address this knowledge gap with a systematic review and meta-analysis. METHODS: We searched MEDLINE, Embase, Cochrane, and Scopus databases through 2017 for studies of screen-detected or undiagnosed celiac disease. Our final analysis included studies that included screening and confirmatory tests (either second serologic analysis or a small intestine biopsy) and provided information on the sex of participants. Studies were excluded if they were performed with specific, high-risk, or referral populations. The primary outcome was the percentage of undetected celiac disease among female and male patients. RESULTS: We identified 4070 articles and analyzed data from 87. Our meta-analysis comprised data from 291,969 study participants. The pooled prevalence of undetected celiac disease in female participants was 0.589% (95% CI, 0.549%-0.629%) and in male participants was 0.415% (95% CI, 0.343%-0.487%). The risk of undetected celiac disease was higher among female than male participants (relative risk [RR], 1.42; 95% CI, 1.27-1.57; P < .00001). The I2 was 5% (low heterogeneity among studies). In subgroup analyses, the RR of celiac disease for girls vs boys was 1.79 (95% CI, 1.44-2.22; P < .00001; I2 = 18%), the RR for female vs male blood donors was 1.13 (95% CI, 0.76-1.69; P = .54; I2 = 0), and the RR for women vs men with villous atrophy was 1.38 (95% CI, 1.07-1.79; P = .01; I2 = 0). CONCLUSIONS: In a systematic review and meta-analysis, we found a higher risk for celiac disease in women than men in an undiagnosed populations (identified through general population screening). The increased risk for celiac disease among girls and women should be considered for screening, diagnosis, and management strategies.


Assuntos
Doença Celíaca/epidemiologia , Doenças não Diagnosticadas/epidemiologia , Autoanticorpos/imunologia , Doença Celíaca/diagnóstico , Doença Celíaca/imunologia , Feminino , Proteínas de Ligação ao GTP/imunologia , Gliadina/imunologia , Humanos , Masculino , Programas de Rastreamento , Prevalência , Proteína 2 Glutamina gama-Glutamiltransferase , Distribuição por Sexo , Transglutaminases/imunologia
7.
Inflamm Bowel Dis ; 25(5): 902-913, 2019 04 11.
Artigo em Inglês | MEDLINE | ID: mdl-30321331

RESUMO

BACKGROUND: Inflammatory bowel diseases (IBDs) are a group of heterogeneous inflammatory conditions affecting the gastrointestinal tract. Although there is considerable evidence linking the gut microbiota to intestinal inflammation, there is limited knowledge on its potential role in the development of extraintestinal manifestations of IBD. METHODS: Four groups of patients were included: IBD-associated arthropathy (IBD-A); IBD without arthropathy (IBD-N); rheumatoid arthritis (RA); and non-IBD, nonarthritis controls. DNA from stool samples was isolated and sequenced using the Illumina platform. Paired-end reads were quality-controlled using SHI7 and processed with SHOGUN. Abundance and diversity analyses were performed using QIIME, and compositional biomarker identification was performed using LEfSe. RESULTS: One hundred eighty patients were included in the analysis. IBD-A was associated with an increased abundance of microbial tyrosine degradation pathways when compared with IBD-N (P = 0.02), whereas IBD-A and RA patients both shared an increased abundance of Clostridiaceae when compared with controls (P = 0.045). We found that history of bowel surgery was a significant source of variability (P = 0.001) among all IBD patients and was associated with decreased alpha diversity and increased abundance of Enterobacteriaceae (P = 0.004). CONCLUSIONS: An increased abundance of gut microbial tyrosine degradation pathways was associated with IBD-A. An increased abundance of Clostridiaceae was shared by both IBD-A and RA patients and suggests a potentially common microbial link for inflammatory arthritis. The increased abundance of Enterobacteriaceae, previously reported in IBD, may be due to the effects of previous bowel surgery and highlights the importance of controlling for this variable in future studies.


Assuntos
Artrite Reumatoide/diagnóstico , Artrite/diagnóstico , Clostridiaceae/patogenicidade , Disbiose/diagnóstico , Microbioma Gastrointestinal , Infecções por Bactérias Gram-Positivas/complicações , Doenças Inflamatórias Intestinais/diagnóstico , Artrite/etiologia , Artrite/patologia , Artrite Reumatoide/etiologia , Artrite Reumatoide/patologia , Estudos de Casos e Controles , Clostridiaceae/genética , Estudos Transversais , Disbiose/etiologia , Disbiose/patologia , Fezes/microbiologia , Feminino , Seguimentos , Infecções por Bactérias Gram-Positivas/microbiologia , Humanos , Doenças Inflamatórias Intestinais/etiologia , Doenças Inflamatórias Intestinais/patologia , Masculino , Pessoa de Meia-Idade , Prognóstico , RNA Ribossômico 16S/genética
8.
Cell Rep ; 20(6): 1269-1277, 2017 08 08.
Artigo em Inglês | MEDLINE | ID: mdl-28793252

RESUMO

The human gut is colonized by a large number of microorganisms (∼1013 bacteria) that support various physiologic functions. A perturbation in the healthy gut microbiome might lead to the development of inflammatory diseases, such as multiple sclerosis (MS). Therefore, gut commensals might provide promising therapeutic options for treating MS and other diseases. We report the identification of human gut-derived commensal bacteria, Prevotella histicola, which can suppress experimental autoimmune encephalomyelitis (EAE) in a human leukocyte antigen (HLA) class II transgenic mouse model. P. histicola suppresses disease through the modulation of systemic immune responses. P. histicola challenge led to a decrease in pro-inflammatory Th1 and Th17 cells and an increase in the frequencies of CD4+FoxP3+ regulatory T cells, tolerogenic dendritic cells, and suppressive macrophages. Our study provides evidence that the administration of gut commensals may regulate a systemic immune response and may, therefore, have a possible role in treatment strategies for MS.


Assuntos
Encefalomielite Autoimune Experimental/terapia , Microbioma Gastrointestinal , Prevotella/imunologia , Probióticos/uso terapêutico , Animais , Linfócitos T CD4-Positivos/imunologia , Células Cultivadas , Células Dendríticas/imunologia , Encefalomielite Autoimune Experimental/microbiologia , Fatores de Transcrição Forkhead/metabolismo , Genes MHC da Classe II , Humanos , Macrófagos/imunologia , Camundongos , Prevotella/patogenicidade , Células Th1/imunologia , Células Th17/imunologia
9.
Clin Immunol ; 178: 10-19, 2017 05.
Artigo em Inglês | MEDLINE | ID: mdl-26057130

RESUMO

Rheumatoid arthritis (RA) occurs two times more often in women than men. B cell depletion has been shown to be efficacious in treating RA. Our previous studies suggested that antigen presentation via B cells results in a sex-specific immune response in DR4 and DR4/DQ8 mice. Here we evaluated the mechanism of efficacy of the B cell depletion in treating arthritis-susceptible DQ8 mice. The data show that arthritic DQ8 mice treated with anti-CD20 antibody in therapeutic protocols show milder disease severity in females as compared to males, which is associated with decreased antibodies to citrullinated proteins and reduced levels of IL-23 and CCL5. Treatment led to significantly increased numbers of T regulatory and monocyte-derived suppressor F4/80+Gr1hi cells in females as compared to male DQ8 mice. Our observations suggest that therapeutic strategies that target B cells may benefit females while functions of DCs might be relatively more important for men than women.


Assuntos
Artrite Experimental/imunologia , Artrite Reumatoide/imunologia , Linfócitos B/imunologia , Quimiocina CCL5/imunologia , Interleucina-23/imunologia , Células Supressoras Mieloides/imunologia , Linfócitos T Reguladores/imunologia , Animais , Antirreumáticos/farmacologia , Artrite Experimental/genética , Artrite Reumatoide/genética , Linfócitos B/efeitos dos fármacos , Antígenos CD28/imunologia , Antígenos CD40/imunologia , Proliferação de Células , Quimiocina CCL5/efeitos dos fármacos , Quimiocinas/efeitos dos fármacos , Quimiocinas/imunologia , Células Dendríticas/efeitos dos fármacos , Células Dendríticas/imunologia , Feminino , Citometria de Fluxo , Cadeias beta de HLA-DQ/genética , Humanos , Interleucina-23/efeitos dos fármacos , Macrófagos/efeitos dos fármacos , Macrófagos/imunologia , Masculino , Camundongos , Camundongos Transgênicos , Receptores de Antígenos de Linfócitos T/imunologia , Rituximab/farmacologia , Caracteres Sexuais , Linfócitos T Reguladores/efeitos dos fármacos
10.
PLoS One ; 11(9): e0162341, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27602574

RESUMO

Rheumatoid arthritis (RA) is an autoimmune disease marked by chronic synovial inflammation and both, genetic and environmental factors are involved in its pathogenesis. Human leukocyte antigen (HLA) DRB1*0401 is associated with susceptibility to develop RA, while cigarette smoke (CS) exposure promotes seropositive disease with increased severity in DRB1*0401+ individuals. Smokers have higher levels of antibodies against citrullinated peptides. In this study, we determined whether the response to a known autoantigen, Vimentin (Vim) is shared epitope specific and how CS influences this response using transgenic-mice carrying RA-susceptible,*0401, and -resistant, *0402, genes. Following relatively brief exposure to CS, peptidyl arginine deiminase (PAD) enzyme expression was increased in murine lungs. Cigarette smoking led to production of Interferon (IFN)-γ with reduced levels of Interleukin (IL)-10 by splenocytes of *0401 mice. In contrast, CS augmented Th2 cytokines along with T-regulatory cells in *0402 mice. An increase in levels of antibodies to native and citrullinated Vim was observed in naïve mice of both strains following CS exposure. Our data showed that both arthritis-susceptible and -resistant mice can generate cellular and humoral immunity to Vim; however CS-induced modulation of host immunity is dependent on the interaction with the host HLA genes.


Assuntos
Artrite Reumatoide/imunologia , Resistência à Doença/imunologia , Fumar/efeitos adversos , Vimentina/imunologia , Animais , Artrite Reumatoide/enzimologia , Artrite Reumatoide/genética , Proliferação de Células , Citocinas/metabolismo , Resistência à Doença/genética , Suscetibilidade a Doenças , Epitopos/imunologia , Feminino , Cadeias HLA-DRB1/genética , Humanos , Hidrolases/metabolismo , Imunidade Humoral , Pulmão/enzimologia , Pulmão/patologia , Contagem de Linfócitos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Desiminases de Arginina em Proteínas , Linfócitos T/imunologia
11.
ACS Chem Biol ; 11(8): 2366-74, 2016 08 19.
Artigo em Inglês | MEDLINE | ID: mdl-27337048

RESUMO

The interaction between the cell-cell adhesion proteins CD2 and CD58 plays a crucial role in lymphocyte recruitment to inflammatory sites, and inhibitors of this interaction have potential as immunomodulatory drugs in autoimmune diseases. Peptides from the CD2 adhesion domain were designed to inhibit CD2:CD58 interactions. To improve the stability of the peptides, ß-sheet epitopes from the CD2 region implicated in CD58 recognition were grafted into the cyclic peptide frameworks of sunflower trypsin inhibitor and rhesus theta defensin. The designed multicyclic peptides were evaluated for their ability to modulate cell-cell interactions in three different cell adhesion assays, with one candidate, SFTI-a, showing potent activity in the nanomolar range (IC50: 51 nM). This peptide also suppresses the immune responses in T cells obtained from mice that exhibit the autoimmune disease rheumatoid arthritis. SFTI-a was resistant to thermal denaturation, as judged by circular dichroism spectroscopy and mass spectrometry, and had a half-life of ∼24 h in human serum. Binding of this peptide to CD58 was predicted by molecular docking studies and experimentally confirmed by surface plasmon resonance experiments. Our results suggest that cyclic peptides from natural sources are promising scaffolds for modulating protein-protein interactions that are typically difficult to target with small-molecule compounds.


Assuntos
Adjuvantes Imunológicos/farmacologia , Antígenos CD2/metabolismo , Antígenos CD58/metabolismo , Peptídeos Cíclicos/farmacologia , Sequência de Aminoácidos , Animais , Adesão Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Dicroísmo Circular , Humanos , Espectrometria de Massas , Camundongos , Modelos Moleculares , Ressonância Magnética Nuclear Biomolecular , Peptídeos Cíclicos/química , Ligação Proteica , Ressonância de Plasmônio de Superfície
12.
Immunology ; 145(3): 313-22, 2015 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-25913295

RESUMO

All vertebrates contain a diverse collection of commensal, symbiotic and pathogenic microorganisms, such as bacteria, viruses and fungi, on their various body surfaces, and the ecological community of these microorganisms is referred to as the microbiota. Mucosal sites, such as the intestine, harbour the majority of microorganisms, and the human intestine contains the largest community of commensal and symbiotic bacteria. This intestinal community of bacteria is diverse, and there is a significant variability among individuals with respect to the composition of the intestinal microbiome. Both genetic and environmental factors can influence the diversity and composition of the intestinal bacteria with the predominant environmental factor being diet. So far, studies have shown that diet-dependent differences in the composition of intestinal bacteria can be classified into three groups, called enterotypes. Other environmental factors that can influence the composition include antibiotics, probiotics, smoking and drugs. Studies of monozygotic and dizygotic twins have proven that genetics plays a role. Recently, MHC II genes have been associated with specific microbial compositions in human infants and transgenic mice that express different HLA alleles. There is a growing list of genes/molecules that are involved with the sensing and monitoring of the intestinal lumen by the intestinal immune system that, when genetically altered, will significantly alter the composition of the intestinal microflora. The focus of this review will be on the genetic factors that influence the composition of the intestinal microflora.


Assuntos
Imunogenética , Mucosa Intestinal/imunologia , Intestinos/imunologia , Microbiota/imunologia , Variação Genética/imunologia , Antígenos HLA/genética , Antígenos HLA/imunologia , Interações Hospedeiro-Patógeno/genética , Interações Hospedeiro-Patógeno/imunologia , Humanos , Mucosa Intestinal/metabolismo , Mucosa Intestinal/microbiologia , Intestinos/microbiologia , Microbiota/genética , Microbiota/fisiologia , Modelos Imunológicos , Receptores Toll-Like/genética , Receptores Toll-Like/imunologia
13.
FEBS Lett ; 588(22): 4244-9, 2014 Nov 17.
Artigo em Inglês | MEDLINE | ID: mdl-24873878

RESUMO

Rheumatoid arthritis (RA) is an autoimmune disease with unknown etiology though both genetic and environmental factors have been suggested to be involved in its pathogenesis. While infections and other environmental factors (e.g. smoking) have been studied extensively and show some association, a direct link between all the factors has been difficult to prove. With the recent advances in technology, it has become possible to sequence the commensals that are residing in our gut. The gut microbiome may provide the missing link to this puzzle and help solve the mystery of many leaky gut syndromes. The gut commensals are involved in maintaining host immune homeostasis and function suggesting that they might be critical in altering the immune system, which leads to autoimmune diseases like RA. Mouse models support the role of the gut microbiota in predisposition to RA. If that is true, the power of gut-derived commensal can be harnessed to our benefit by generating a biomarker profile along with genetic factors to define individuals at risk and by altering the gut microbial composition using various means.


Assuntos
Artrite Reumatoide/microbiologia , Suscetibilidade a Doenças , Trato Gastrointestinal/microbiologia , Microbiota , Animais , Artrite Reumatoide/etiologia , Artrite Reumatoide/imunologia , Humanos , Hipótese da Higiene
14.
Clin Immunol ; 152(1-2): 25-35, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24631425

RESUMO

Individuals carrying DRB1*0401 who smoke cigarettes are at an increased risk of developing severe seropositive RA. To determine how cigarette smoke (CS) interacts with host genetic factors in the induction of RA-associated autoimmunity, we used transgenic mice carrying the RA-susceptible HLA genes DR4 and DQ8, but lacking all endogenous murine class II molecules. Cigarette smoke exposure augmented peptidylarginine deiminase (PAD) enzyme expression, and enhanced immune responses to citrullinated collagen and vimentin. Here we show for the first time that DQ molecules can present citrullinated peptides much more efficiently than native peptides. Interestingly, CS exposure suppressed collagen-induced arthritis (CIA) in DRB1*0401 mice although innate immune response was enhanced. On the other hand, CS exposure exacerbated CIA in DQ8 mice, which was accompanied by an increased expression of Th17 gene transcripts in lungs. These observations suggest that cigarette smoke promotes antigen-specific autoimmunity that is profoundly influenced by host genetic factors.


Assuntos
Artrite Reumatoide/imunologia , Antígenos HLA-DQ/genética , Antígeno HLA-DR4/genética , Fumaça/efeitos adversos , Fumar/efeitos adversos , Animais , Artrite Experimental/genética , Artrite Experimental/imunologia , Artrite Reumatoide/genética , Autoimunidade/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Colágeno/imunologia , Citocinas/sangue , Células Dendríticas/efeitos dos fármacos , Células Dendríticas/imunologia , Feminino , Predisposição Genética para Doença , Antígenos HLA-DQ/imunologia , Antígeno HLA-DR4/imunologia , Cadeias HLA-DRB1/genética , Cadeias HLA-DRB1/imunologia , Hidrolases/metabolismo , Pulmão/citologia , Pulmão/imunologia , Ativação Linfocitária/efeitos dos fármacos , Masculino , Camundongos , Camundongos Transgênicos , Desiminases de Arginina em Proteínas , Células Th17/efeitos dos fármacos , Células Th17/imunologia , Células Th2/efeitos dos fármacos , Células Th2/imunologia , Vimentina/imunologia
15.
J Med Chem ; 54(15): 5307-19, 2011 Aug 11.
Artigo em Inglês | MEDLINE | ID: mdl-21755948

RESUMO

Cell adhesion molecule CD2 and its ligand CD58 provide good examples of protein-protein interactions in cells that participate in the immune response. To modulate the cell adhesion interaction, peptides were designed from the discontinuous epitopes of the ß-strand region of CD2 protein. The two strands were linked by a peptide bond. ß-Strands in the peptides were nucleated by inserting a ß-sheet-inducing (D)-Pro-Pro sequence or a dibenzofuran (DBF) turn mimetic with key amino acid sequences from CD2 protein that binds to CD58. The solution structures of the peptides (5-10) were studied by NMR and molecular dynamics simulations. The ability of these peptides to inhibit cell adhesion interaction was studied by E-rosetting and lymphocyte epithelial assays. Peptides 6 and 7 inhibit the cell adhesion activity with an IC(50) of 7 and 11 nM, respectively, in lymphocyte epithelial adhesion assay. NMR and molecular modeling results indicated that peptides 6 and 7 exhibited ß-hairpin structure in solution.


Assuntos
Antígenos CD2/química , Antígenos CD58/química , Adesão Celular/efeitos dos fármacos , Peptídeos/química , Peptídeos/farmacologia , Sequência de Aminoácidos , Animais , Antígenos CD2/imunologia , Antígenos CD58/imunologia , Células CACO-2 , Adesão Celular/imunologia , Sobrevivência Celular/efeitos dos fármacos , Humanos , Células Jurkat , Camundongos , Simulação de Dinâmica Molecular , Ressonância Magnética Nuclear Biomolecular , Peptídeos/síntese química , Peptídeos/imunologia , Conformação Proteica , Mapeamento de Interação de Proteínas , Formação de Roseta , Relação Estrutura-Atividade , Linfócitos T/efeitos dos fármacos
16.
J Autoimmun ; 35(1): 1-9, 2010 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-20061120

RESUMO

HLA class II allele DRB1*0401 is associated with predisposition to Rheumatoid Arthritis in humans as well as collagen-induced arthritis in mice. Predominantly females develop arthritis in humans and DR4 transgenic mice; however the mechanism of sex-bias is still unknown. We have investigated the molecular basis by which DR4 is associated with sex-bias of arthritis. Here we show that differential antigen-specific immune mechanisms in DR4 male and female mice lead to increased susceptibility in female mice. B cells are hyperactive and present DR-restricted peptides robustly in females compared to males. Antigen-specific response showed that females produced B cell modulating cytokines like IL-13 while males produced IFNgamma. Male transgenic mice have higher number of T and B regulatory cells. An exogenous supply of 17beta estradiol in male mice led to enhanced expression of DR4 and antigen-specific response to DR4-restricted peptides. On the other hand, castration increased the incidence of arthritis. We propose that sex-bias in arthritis involves B cells and presentation of antigen by HLA-DR4 leading to activation of autoreactive cells and autoantibodies production in females, while regulatory B cells in males protect them from pathogenesis. The transgenic mice expressing RA susceptible haplotype simulate human RA and may be valuable to study gender differences observed in patients.


Assuntos
Artrite Reumatoide/imunologia , Linfócitos B/metabolismo , Antígenos HLA-DR/metabolismo , Fatores Sexuais , Linfócitos T/metabolismo , Animais , Apresentação de Antígeno/efeitos dos fármacos , Artrite Reumatoide/epidemiologia , Artrite Reumatoide/genética , Autoantígenos/imunologia , Linfócitos B/efeitos dos fármacos , Linfócitos B/imunologia , Linfócitos B/patologia , Castração , Células Cultivadas , Estradiol/administração & dosagem , Feminino , Predisposição Genética para Doença , Antígenos HLA-DR/genética , Antígenos HLA-DR/imunologia , Cadeias HLA-DRB1 , Humanos , Tolerância Imunológica , Incidência , Interferon gama/metabolismo , Interleucina-13/metabolismo , Ativação Linfocitária/efeitos dos fármacos , Masculino , Camundongos , Camundongos SCID , Camundongos Transgênicos , Fragmentos de Peptídeos/imunologia , Linfócitos T/efeitos dos fármacos , Linfócitos T/imunologia , Linfócitos T/patologia
17.
J Mol Cell Cardiol ; 42(6): 1054-64, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17499268

RESUMO

Most individuals have viral infections at some point in their life, however, only few develop autoreactivity to cardiac myosin following infection resulting in myocarditis suggesting a genetic predisposition. Most mouse models of myocarditis are induced by viral infection or by immunization with cardiac myosin. We generated HLA-DR3.Abetao and HLA-DQ8.Abetao transgenic mice in NOD and HLA-DQ8.Abetao in B10 background to study spontaneous autoimmunity. A high mortality was observed in NOD.DQ8 female mice 16 weeks or older. Echocardiography showed marked systolic dysfunction. Histopathology of various organs revealed an enlarged heart with mononuclear infiltrate consisting of CD4 and Mac-1+ cells and myocyte necrosis. The autoimmunity was associated with the presence of spontaneous autoreactive T cells and antibodies to cardiac myosin. Serologically, mice were negative for all known mouse viruses. NOD.DR3.Abetao, the transgene negative littermates, NOD, and B10.DQ8 Abetao mice had no gross or microscopic cardiac pathology. Spontaneous cellular and humoral response to cardiac myosin suggests that NOD.DQ8 may harbor autoreactive cells that can lead to spontaneous myocarditis and dilated cardiomyopathy. HLA-DQ8 is required for the predisposition to the spontaneous autoreactivity while NOD background influences onset and progression of disease. This model of myocarditis occurs predominantly in female mice and may provide insight into the pathogenesis of heart disease in women.


Assuntos
Antígenos HLA-DQ/fisiologia , Antígeno HLA-DR3/fisiologia , Miocardite/genética , Miocardite/imunologia , Animais , Formação de Anticorpos , Autoimunidade , Antígenos CD4/imunologia , Miosinas Cardíacas/imunologia , Modelos Animais de Doenças , Eletrocardiografia , Feminino , Antígenos HLA-DQ/genética , Antígeno HLA-DR3/genética , Humanos , Imunidade Celular , Imuno-Histoquímica , Macrófagos/imunologia , Camundongos , Camundongos Endogâmicos NOD , Camundongos Knockout , Camundongos Transgênicos , Miocardite/mortalidade , Miocardite/patologia , Fatores Sexuais , Linfócitos T/imunologia
18.
J Immunol ; 174(2): 1118-25, 2005 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-15634938

RESUMO

CD28 is required to achieve optimal T cell activation to an Ag. To determine the role CD28 costimulation plays in collagen-induced arthritis, we have generated DQ8 transgenic, CD28-deficient mice. DQ8 mice deficient for CD28 had comparable numbers of CD4 and CD8 T cells as DQ8.CD28(+/+) mice. DQ8.CD28(-/-) mice develop collagen-induced arthritis with delayed onset and less severity than DQ8.CD28(+/+) mice. T cells from DQ8.CD28(-/-) mice did not respond to type II collagen efficiently in vitro, although the response to DQ8-restricted peptides was similar to that in the parent mice. There was no functional defect in T cells as observed by proliferation with Con A. Cytokine analysis from in vitro study showed the production of high levels of the inflammatory cytokine, IFN-gamma, in response to type II collagen. We observed an increase in CD4(+)CD28(-)NKG2D(+) cells after immunization, suggesting an important role for cells bearing this receptor in the disease process. CD28(-/-) mice also have an increased number of DX5(+) cells compared with CD28(+/+) mice, which can lead to the production of high levels of IFN-gamma. DQ8.CD28(-/-) mice had an increased number of cells bearing other costimulatory markers. Cells from DQ8.CD28(-/-) mice exhibited a lower proliferation rate and were resistant to activation-induced cell death compared with DQ8.CD28(+/+) mice. This study supports the idea that CD28 plays a crucial role in the regulation of arthritis. However, in the absence of CD28 signaling, other costimulatory molecules can lead to the development of disease, thus indicating that the requirement for CD28 may not be absolute in the development of arthritis.


Assuntos
Artrite Experimental/genética , Artrite Experimental/imunologia , Antígenos CD28/fisiologia , Colágeno Tipo II , Antígenos HLA-DQ/genética , Animais , Biomarcadores/análise , Antígenos CD28/genética , Morte Celular/genética , Morte Celular/imunologia , Feminino , Humanos , Imunidade Inata/genética , Interferon gama/biossíntese , Células Matadoras Naturais/imunologia , Células Matadoras Naturais/metabolismo , Ativação Linfocitária/genética , Masculino , Camundongos , Camundongos Knockout , Camundongos Transgênicos , Membro 7 da Superfamília de Receptores de Fatores de Necrose Tumoral/fisiologia
19.
Am J Med Sci ; 327(4): 180-7, 2004 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-15084913

RESUMO

Collagen-induced arthritis is an animal model for rheumatoid arthritis that shares a number of clinical, hematologic, serologic, and radiographic features with human disease. Predisposition to rheumatoid arthritis has been associated with major histocompatibility complex (MHC) class II genes, HLA-DRB*0401/DQB1*0302 and resistance to DRB1*0402 and DQ6 genes. Animal models allow one to study the genetics and immunologic processes of individual genes involved in the complex human diseases. To study the interactions between class II molecules and to define their role in arthritis, the authors generated HLA-DR and -DQ transgenic mice. HLA transgenes are expressed on cell surface and can positively select CD4 cells. A peripheral tolerance is maintained to the trans-genes even though an efficient T cell response to immunodominant antigens similar to human T cells is observed. Using HLA-DQ/DR double transgenic mice, the studies show that complementation between DQ and DR molecules contributes to predisposition to and severity of, or protection from, arthritis. Thus, these mice provide a powerful tool to understand the role of HLA molecules in the predisposition to and immunotherapy for human disease.


Assuntos
Artrite Experimental/imunologia , Artrite Reumatoide/imunologia , Antígenos HLA-DQ/genética , Antígenos HLA-DR/genética , Complexo Principal de Histocompatibilidade/genética , Sequência de Aminoácidos , Animais , Artrite Experimental/genética , Artrite Reumatoide/genética , Galinhas , Suscetibilidade a Doenças , Epitopos , Antígenos HLA-DQ/imunologia , Antígenos HLA-DR/imunologia , Haplótipos , Humanos , Complexo Principal de Histocompatibilidade/imunologia , Camundongos , Camundongos Transgênicos , Peptídeos/genética , Peptídeos/imunologia , Peptídeos/metabolismo , Linfócitos T/imunologia , Linfócitos T/metabolismo
20.
J Clin Invest ; 112(12): 1843-50, 2003 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-14679179

RESUMO

Relapsing polychondritis is a multisystem autoimmune disease involving cartilage destruction but no known causative antigen. HLA-DQ8 has been associated with various autoimmune diseases in humans. To study the role of DQ8 in autoimmune diseases, we have generated transgenic mice expressing DQ8 (DQA1*0301, DQB1*0302) in a NOD background lacking endogenous class II molecules (Abetao). Upon immunization with type II collagen (CII), 85% of NOD.DQ8 mice develop severe experimental polychondritis, auricular chondritis, and polyarthritis, with clinical and histological similarities to relapsing polychondritis (RP) in humans. CII-immunized mice mount a T cell response and produce Ab's to type IX collagen (CIX) and self-CII. Transgene-negative littermates do not develop any serological and clinical manifestations following immunization. B10.DQ8 transgenic mice develop polyarthritis and Ab's to CII only. The susceptibility to auricular chondritis in NOD.DQ8 mice can be attributed to response to CIX. A higher number of activated cells, CD4+CD44(hi)CD62L(lo), and lower regulatory cells CD4+CD152+CD25+ were observed in NOD.DQ8 mice compared with B10.DQ8 mice. The NOD.DQ8 mice provide a model of RP with a high disease incidence and multiple organ involvement to investigate putative autoantigen and regulatory cells involved in disease pathogenesis. An experimental model restricted by the human class II molecule will be valuable when studying the role of various collagens in immunologic and pathologic responses in human RP.


Assuntos
Policondrite Recidivante/genética , Animais , Antígenos CD , Antígenos de Diferenciação/biossíntese , Antígenos CD4/biossíntese , Antígeno CTLA-4 , Cartilagem/patologia , Divisão Celular , Galinhas , Colágeno/metabolismo , Citocinas/metabolismo , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Orelha/patologia , Feminino , Citometria de Fluxo , Antígenos HLA-DQ/metabolismo , Humanos , Receptores de Hialuronatos/biossíntese , Selectina L/biossíntese , Masculino , Camundongos , Camundongos Endogâmicos NOD , Camundongos Transgênicos , Receptores de Interleucina-2/biossíntese , Linfócitos T/citologia , Fatores de Tempo , Transgenes
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA